Lung Cancer Prognosis Market likely to witness an impressive Healthy CAGR by 2025, as estimated by Stratview Research
Not only the report offers the market size but also details about the market segmentation with its share. Stratview Research also extends its research to offer a forecast of the market during the period of 2018 – 2025, to provide the clients with base knowledge of the market and make strategies to have beneficial results ahead.
Click here for a Free Sample of the report (additional insights inside):
In the Lung Cancer Diagnostics segment, Thermofischer, Roche, Biomerieux are few of the market leaders but are they going to get tougher competitions from the newbies such as Astraeus Technologies, Zebra Medical, Deton, Oncocyte and many more that are entering the specialized diagnostics market. It might be interesting to consider that while 50% of the oncologists decide (decision makers) the type of tests and the frequency of repeat tests, shared decision making process is equally high among the Lung Cancer Management Market. The opportunity is huge, NSCLC cases accounts for 85% of the recorded lung cancer incidence worldwide, > 60% require diagnosis, medicine for maintenance, pain and other side effects.
Considering the complications and limitations in lung cancer surgery (not all patients are eligible), still the market is expected to grow steadily at a CAGR of 6.29%, over the course of forecast period (2019-2025). The demand for NSCLC surgery is high, thus the market size of 99%. In some cases surgery is not recommended, when the tumor is found in proximity with the heart, the esophagus – the food pipe, the wind pipe and major blood vessels. The demand for NSCLC surgery is expected to grow rapidly with a CAGR of 6.31% over the course of seven years. The study on the Lung Cancer Management Market by Stratview also states that Lobectomy (sub segment under Lung Cancer Surgery) results in lowest recurrence rate and higher survival rate as compared to other surgery type. Hence it is the highly referred type of surgery procedure for NSCLC cases. One of the companies, Auris is most promising in this segment and has a brighter future ahead. This segment also foresees competition from Chinese companies such as IFLYTEK who are strong contenders in the global market.
Among the different segments of Global Lung Cancer Management Market, connected health or Apps for Lung cancer maintenance or management are few. However, the segment is promising, as researchers believe that App based software can help in treatment adherence, keeping track of medical records (insurance companies, medical centres). Developed markets such as USA, UK, Germany, France, Japan, China and Australia are the near term opportunities.
Lung cancer patients need nutritional supplements throughout their treatment phase followed by recovery and maintenance phase. The study from Stratview Research also looks at the aspects of sales and marketing, buying patterns of end users which can help companies such as Abbott, Danone, Nestle, B Braun and more gauge the market and look at the changing preferences of the market in regions such as Asia Pacific, Europe and North America.
Finally the report on Lung Cancer Prognosis also focuses on the regional aspects and gives the reader the flexibility to consider between global market as whole or regions in particular. It is imperative to look at this market as connected as out of the prevalent cases of Lung cancer are potential candidates of diagnosis and of the diagnosed pool a higher percentage will require medication or surgery, there will be few drop outs and few gaps, more or less all the above will need apps or Healthcare IT products to monitor drug adherence, doctor access, and above all long term nutritional supplement.
Hence, readers may consider this inter-linked market under the Lung cancer management market and consider the opportunities that exist in each segment from 2019-2025.
Click here for description of the report:
Highlights of the Report:
For the first time in market, one report exclusively touches upon the demands, gaps and opportunities of the global lung cancer market while covering Lung Cancer Diagnostics, Lung Cancer Therapeutics, Lung Cancer Nutritional supplement, Lung Cancer Surgery and Lung Cancer Connected Health Market. The management of Lung cancer varies with region, by decision makers, by site of treatment, by type of lung cancer, by age, by decision making process, by cost of therapy at each stage and by various other parameters. Why Lung Cancer? Because WHO and other health agencies consider it to be the number One killer across the world.
If we consider the Lung Cancer Management Market from the stakeholder’s perspective, then drugs approved for Small Cell Lung Cancer will not be applicable for Non-Small Cell Lung Cancer. What is the future of the top 10 best-selling drugs in this segment, will they stay or fade away? Among the class of drugs, will Angiogenesis Inhibitors take a dip in sales by 2025 or will it overtake the sales of drugs in the class Immune Checkpoint Inhibitors? What is the market for BRAF / MEK Inhibitors? Who all are the active players and who are newbies. Will the differential cost of therapeutics across the regions impact the drug sales in North America versus APAC? In the Small Scale Lung Cancer Therapeutics, immunotherapy drugs will play a major role in the next 7 years and may grow a CAGR of 7.44% globally however the same class of drugs might grow at a CAGR of 10.59% in the Non-Small Scale Lung Cancer Therapeutics Market in the same time period.
Considering that all the drugs mentioned above have a bright future till 2025, how many companies would like to compete in this market. How will the new joiners react if they consider that the market had a potential of USD 17.11 Billion alone in 2018 and is likely to grow at a CAGR of 8.28% globally till 2025.
Check out the Table of Contents here:
Features of the Report
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.
The Lung Cancer Prognosis Market analysis report discusses the following heads in great detail:
• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors
400 Renaissance Center,
Detroit, Michigan, MI 48243
United States of America
Phone No. +1-313-307-4176
Know more about us and our reports:
Stratview Research has been offering its insightful reports and custom researches to the interested clients in some of important industry sectors such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. The data is collected for the reports is collected from reliable sources and is analysed carefully to come up with an end result that is resourceful and worthy for the interesting clients.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Cancer Prognosis Market likely to witness an impressive Healthy CAGR by 2025, as estimated by Stratview Research here
News-ID: 1863962 • Views: 139
More Releases from Stratview Research
Floor Adhesives Market Size to Grow at a CAGR of 5.1% by 2023
Floor Adhesives Market is expected to grow at a CAGR of 5.1% during 2018-2023, according to a newly added report by Stratview Research. This represents an attractive growth opportunity in the entire ecosystem of the market. Growing global construction industry, increasing consumption of adhesives globally, increasing use of water-based adhesives over solvent-based adhesives to reduce VOC emissions, replacement of mechanical fastening systems with adhesives, and the ability of adhesives to
Harmonic Filter Market Size to Grow at a CAGR of 6.4% by 2023
Harmonic Filter Market is expected to grow at a CAGR of 6.4% during 2018-2023, according to a newly added report by Stratview Research. Increasing use of power electronics that basically operates through electronic switching, increasing levels of harmonic distortions of voltage and current waveforms in power systems, increasing usage of variable frequency drives (VFDs), rising demand from the data centers and IT industries, increasing number of metal arc furnaces worldwide,
Sprayed-in-Place Pipe (SIPP) Market Size to Grow at a CAGR of 4.4% by 2024
Sprayed-in-Place Pipe (SIPP) Market is expected to grow at a CAGR of 4.4% during 2019-2024, according to a newly added report by Stratview Research. The SIPP market is mainly driven by the spending of government and municipal corporations towards infrastructure rehabilitation. Most of the water main pipes, wastewater pipes, and storm pipes in the major countries, such as the USA, Germany, and Canada, have reached or almost reaching their retirement
Trenchless Pipe Rehabilitation Market Size to Grow at an impressive CAGR by 2025
The trenchless pipe rehabilitation market is projected to grow at an impressive rate over the next five years to reach an estimated value of US$ 6.4 billion in 2025., according to a newly added report by Stratview Research. The market is mainly driven by the increase in spending of government and municipal corporations of various countries towards infrastructure rehabilitation. Furthermore, increasing awareness towards trenchless (no-dig) technologies in many nations, especially
More Releases for Lung
Interstitial Lung Disease Therapeutics - Pipeline Analysis 2018
Interstitial lung disease is a type of inflammatory disease that affects and thickens the interstitium of the lungs. Download the sample report @ https://www.pharmaproff.com/request-sample/1126 The interstitium is a lace like network of the tissue that provide support to the air sacs and the capillaries in the interstitium which allows the gas exchange between the blood and alveolar tissues. Get the detailed analysis @ https://www.pharmaproff.com/report/interstitial-lung-disease-therapeutics-pipeline-analysis Some of the types of the condition include
Lung Cancer and Therapies Meet 2019
Lexis is the world best platform for all the researchers to showcase their on-going research work through Oral/Poster presentations in front of the international audience, provided with additional opportunities for expanding their research work by conducting workshops and by exhibiting products. It gives you the global exposure and helps to associate with the present and potential researchers who discover novel techniques to treat Lung Cancer with different approach. This meet enlightens
Lung Cancer Surgery Market Forecasts (2016-2021)
Lung Cancer Surgery Market was worth USD 21.58 billion in 2016 and is expected to reach USD 30.32 billion by 2021 with a CAGR of 6.92 %. Lung Cancer is a type of Cancer that starts in Trachea, Bronchus or lung Tissue. They are many ways to treat Lung Cancer. Some of them are Chemotherapy, Radiotherapy, Laser therapy, and Surgery. Surgery involves removal of infected section from lungs. There are many
Acute Lung Injury Market Technological breakthroughs 2025
Acute lung injury (ALI) is commonly characterized by hypoxia, lung complication and pulmonary edema. This condition causes inflammation or direct injury to the lungs. Generally, the symptoms of this disease are divided into two forms namely, primary ALI and secondary ALI. Primary ALI is caused by the conditions like pneumonia. While, secondary ALI is mainly caused by indirect injury to the lungs. Inhalation injury, pulmonary contusions, sever trauma, shock are
Lung Cancer Treatment Market Outlook to 2022
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions The global lung cancer drugs market was valued at $3.1bn in 2016 and is forecast to grow at a healthy 31.1% CAGR between 2016
Europe Lung Cancer Drug Pipeline Analysis
The most common type of cancer in terms of incidence and mortality rate is Lung cancer. Lung cancer is a disease in which the lining of the cell of the lung tissue has an uncontrollable growth which in turn leads to the formation of tumor. There are two main types of lung cancer; small cell lung cancer which accounts for about 20% and non-small cell lung cancer (NSCLC) that accounts